跳至主要内容
临床试验/NCT04487301
NCT04487301已完成不适用

A Cross-Sectional Non-Interventional Study to Assess Walking Performance, Quality of Life, Vascular Function, and Lower Limb Arterial Calcification in Subjects With Peripheral Artery Disease and ESKD Receiving Hemodialysis

Sanifit Therapeutics S. A.7 个研究点 分布在 1 个国家目标入组 36 人开始时间: 2020年11月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
36
试验地点
7
主要终点
Activity Patterns

研究概览

简要总结

A cross-sectional, non-interventional study to assess walking performance, vascular function, and lower limb calcification in subjects with peripheral artery disease and end-stage kidney disease (PAD-ESKD) receiving hemodialysis.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Cross Sectional

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥55 years of age or ≥45 years of age with diabetes
  • Receiving maintenance HD in a clinical setting for at least 2 weeks prior to screening
  • Resting ABI <0.90 in either leg OR Resting TBI <0.70 in either leg
  • Symptomatic as characterized by a limitation in exercise performance

排除标准

  • Above-ankle amputation
  • Chronic limb-threatening ischemia (Rutherford 4-6)
  • Non-ambulatory status
  • A condition other than PAD that limits ability to walk
  • Open or endovascular revascularization within 3 months prior to baseline.
  • Illnesses, conditions, or planned surgeries within the study period that will interfere with the interpretation of the study results

结局指标

主要结局

Activity Patterns

时间窗: Functional activity measurements will be collected daily beginning at the completion of screening and daily for the duration of the subject's participation of up to 4 weeks.

Actigraphy measurements as 24 hour intervals of motion using an accelerometer device

San Diego Claudication Questionnaire

时间窗: Administered once during Day 1 of the screening visit during subject's participation of up to 4 weeks.

Will categorize the subject's perception of the leg symptoms associated with PAD

Walking Impairment Questionnaire

时间窗: Administered once during Week 1 during subject's participation of up to 4 weeks.

Will evaluate the subjects personal perception of walking ability.

Toe Brachial Index

时间窗: Will be conducted once in a vascular laboratory during the screening visit or visits during the subject's participation of up to 4 weeks

Compares blood pressure in upper extremities and lower extremities

PAD Quality of Life

时间窗: Administered once during Week 1 during subject's participation of up to 4 weeks.

Will evaluate information about the subject's perception of social relationships, self-concepts and feelings, symptoms and limitations in physical functioning, fear and uncertainly, and positive adaptation.

Six Minute Walk Test

时间窗: Two six minute walk tests will be conducted separated by 5-7 days during Week 1 during the subject's participation of up to 4 weeks.

Walking distance in meters completed over a duration of 6 minutes

Pulse Wave Velocity - Sub-Study

时间窗: Will be conducted once in a vascular lab for subjects participating the in the sub-study during Week 3 of the subjects participation of 4 weeks.

Measures arterial stiffness

Ankle Brachial Index

时间窗: Will be conducted once in a vascular laboratory during the screening visit or visits during the subject's participation of up to 4 weeks

Compares blood pressure in upper extremities and lower extremities

EQ-SD-SL Health Questionnaire

时间窗: Administered once during Week 1 during subject's participation of up to 4 weeks

Will evaluate the subject's perception of overall health status, mobility, self-care, usual activities, pain or discomfort, and anxiety or depression.

Flow-Mediated Dilation - Sub-Study

时间窗: Will be conducted once in a vascular lab for subjects participating the in sub-study during Week 3 of the subjects participation of 4 weeks.

Measures the ability of blood vessels to dilate

Lower limb calcification measurements

时间窗: Will be conducted once in subjects participating the in sub-study during Week 3 of the subjects participation of up to 4 weeks.

A non-contrast computed tomography scan of the lower extremities will be evaluated for arterial calcification.

Nitroglycerin-Medicated Dilation - Sub-Study

时间窗: Will be conducted once in a vascular lab for subjects participating the in sub-study during Week 3 of the subjects participation of 4 weeks.

Measures the ability of blood vessels to dilate after administration of nitroglycerin

次要结局

未报告次要终点

研究者

发起方
Sanifit Therapeutics S. A.
申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验